Valentini C - Search Results

1

Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review.

Elkhamisy SA, Valentini C, Lattermann A, Radhakrishna G, Künzel LA, Löck S, Troost EGC. Elkhamisy SA, et al. Among authors: valentini c. Cancers (Basel). 2023 Jul 25;15(15):3771. doi: 10.3390/cancers15153771. Cancers (Basel). 2023. PMID: 37568587 Free PMC article. Review.

2

Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience.

Mattiucci GC, Valentini C, D'Agostino GR, Augurio A, Capirci C, De Paoli A, Genovesi D, Huscher A, Iannone T, Pani G, Rosetto ME, Sciacero P, Manfrida S, Corazzi F, Fusco V, Luppattelli M, Mangiacotti MG, Melano A, Murino P, Niespolo R, Osti MF, Picardi V, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: valentini c, valentini v. Tumori. 2015 Jan-Feb;101(1):91-7. doi: 10.5301/tj.5000265. Tumori. 2015. PMID: 25712602

3

Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system.

Gambacorta MA, Valentini C, Dinapoli N, Boldrini L, Caria N, Barba MC, Mattiucci GC, Pasini D, Minsky B, Valentini V. Gambacorta MA, et al. Among authors: valentini c, valentini v. Acta Oncol. 2013 Nov;52(8):1676-81. doi: 10.3109/0284186X.2012.754989. Epub 2013 Jan 22. Acta Oncol. 2013. PMID: 23336255

4

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG. Linge A, et al. Among authors: valentini c. Radiother Oncol. 2016 Dec;121(3):364-373. doi: 10.1016/j.radonc.2016.11.008. Epub 2016 Nov 29. Radiother Oncol. 2016. PMID: 27913065

5

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.

Bütof R, Gumina C, Valentini C, Sommerer A, Appold S, Zips D, Löck S, Baumann M, Troost EGC. Bütof R, et al. Among authors: valentini c. Clin Transl Radiat Oncol. 2017 Nov 6;7:36-42. doi: 10.1016/j.ctro.2017.09.010. eCollection 2017 Dec. Clin Transl Radiat Oncol. 2017. PMID: 29594227 Free PMC article.

6

Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization.

Kurz C, Süss P, Arnsmeyer C, Haehnle J, Teichert K, Landry G, Hofmaier J, Exner F, Hille L, Kamp F, Thieke C, Ganswindt U, Valentini C, Hölscher T, Troost E, Krause M, Belka C, Küfer KH, Parodi K, Richter C. Kurz C, et al. Among authors: valentini c. Z Med Phys. 2019 Aug;29(3):216-228. doi: 10.1016/j.zemedi.2018.10.003. Epub 2018 Nov 5. Z Med Phys. 2019. PMID: 30409729

7

Utility of fiducial markers for target positioning in proton radiotherapy of oesophageal carcinoma.

Apolle R, Brückner S, Frosch S, Rehm M, Thiele J, Valentini C, Lohaus F, Babatz J, Aust DE, Hampe J, Troost EGC. Apolle R, et al. Among authors: valentini c. Radiother Oncol. 2019 Apr;133:28-34. doi: 10.1016/j.radonc.2018.12.016. Epub 2019 Jan 14. Radiother Oncol. 2019. PMID: 30935578

8

Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.

Dutz A, Agolli L, Bütof R, Valentini C, Baumann M, Lühr A, Löck S, Krause M. Dutz A, et al. Among authors: valentini c. Radiother Oncol. 2020 Feb;143:108-116. doi: 10.1016/j.radonc.2019.12.024. Epub 2020 Feb 8. Radiother Oncol. 2020. PMID: 32044170

9

Modelling of late side-effects following cranial proton beam therapy.

Dutz A, Lühr A, Agolli L, Bütof R, Valentini C, Troost EGC, Baumann M, Vermeren X, Geismar D, Lamba N, Lebow ES, Bussière M, Daly JE, Bussière MR, Krause M, Timmermann B, Shih HA, Löck S. Dutz A, et al. Among authors: valentini c. Radiother Oncol. 2021 Apr;157:15-23. doi: 10.1016/j.radonc.2021.01.004. Epub 2021 Jan 19. Radiother Oncol. 2021. PMID: 33482232

10

Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.

Dutz A, Lühr A, Troost EGC, Agolli L, Bütof R, Valentini C, Baumann M, Vermeren X, Geismar D, Timmermann B, Krause M, Löck S. Dutz A, et al. Among authors: valentini c. Radiother Oncol. 2021 Jul;160:69-77. doi: 10.1016/j.radonc.2021.04.008. Epub 2021 Apr 17. Radiother Oncol. 2021. PMID: 33872640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page